4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001104659-21-130030
10% owner acquired 680,825 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Merck KGaA · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-26 | Conversion : show line 1 in the form | +416,060 | 416,060 | I |
| 2021-10-26 | Conversion : show line 2 in the form | +264,765 | 680,825 | I |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-26 | Conversion : show line 3 in the form Series B Preferred Stock | −3,952,568 | 0 | I |
| 2021-10-26 | Conversion : show line 4 in the form Series C Preferred Srock | −2,515,271 | 0 | I |
Loading xslF345X03/tm2130646-26_4seq1.xml…